- Home
- CLPR vs VRCA Comparison
CLPR vs VRCA Comparison
Compare CLPR & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPR
- VRCA
- Stock Information
- Founded
- CLPR 2015
- VRCA 2013
- Country
- CLPR United States
- VRCA United States
- Employees
- CLPR N/A
- VRCA N/A
- Industry
- CLPR Real Estate Investment Trusts
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- CLPR Real Estate
- VRCA Health Care
- Exchange
- CLPR Nasdaq
- VRCA Nasdaq
- Market Cap
- CLPR 57.8M
- VRCA 54.0M
- IPO Year
- CLPR 2017
- VRCA 2018
- Fundamental
- Price
- CLPR $3.57
- VRCA $0.80
- Analyst Decision
- CLPR
- VRCA Hold
- Analyst Count
- CLPR 0
- VRCA 5
- Target Price
- CLPR N/A
- VRCA $6.00
- AVG Volume (30 Days)
- CLPR 89.5K
- VRCA 672.3K
- Earning Date
- CLPR 07-31-2025
- VRCA 08-13-2025
- Dividend Yield
- CLPR 10.64%
- VRCA N/A
- EPS Growth
- CLPR N/A
- VRCA N/A
- EPS
- CLPR N/A
- VRCA N/A
- Revenue
- CLPR $152,413,000.00
- VRCA $7,179,000.00
- Revenue This Year
- CLPR N/A
- VRCA $171.87
- Revenue Next Year
- CLPR N/A
- VRCA $71.38
- P/E Ratio
- CLPR N/A
- VRCA N/A
- Revenue Growth
- CLPR 8.63
- VRCA N/A
- 52 Week Low
- CLPR $3.38
- VRCA $0.38
- 52 Week High
- CLPR $7.12
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- CLPR 39.88
- VRCA 68.47
- Support Level
- CLPR $3.65
- VRCA $0.52
- Resistance Level
- CLPR $3.94
- VRCA $0.67
- Average True Range (ATR)
- CLPR 0.16
- VRCA 0.08
- MACD
- CLPR -0.02
- VRCA 0.03
- Stochastic Oscillator
- CLPR 0.00
- VRCA 70.47
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.